|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.56 USD | +2.19% |
|
+9.52% | -10.03% |
Company Valuation: Legend Biotech Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,735 | 7,175 | 8,357 | 10,938 | 5,969 | 3,613 | 3,613 | - |
| Change | - | 92.11% | 16.46% | 30.89% | -45.43% | -39.48% | 0% | - |
| Enterprise Value (EV) 1 | 3,233 | 6,446 | 7,855 | 9,959 | 4,496 | 3,266 | 2,840 | 2,714 |
| Change | - | 99.39% | 21.86% | 26.78% | -54.85% | -27.37% | -13.02% | -4.44% |
| P/E ratio | -11x | -17x | -17.8x | -20.5x | -33.9x | -13.4x | -163x | 13.3x |
| PBR | 13.4x | 15.3x | - | 8.75x | 5.74x | 4.82x | 3.6x | 2.77x |
| PEG | - | -2.42x | -8.13x | -4.1x | 0.5x | -0.2x | 1.8x | -0x |
| Capitalization / Revenue | 49.4x | 79.9x | 71.4x | 38.4x | 9.52x | 3.9x | 2.48x | 2x |
| EV / Revenue | 42.7x | 71.8x | 67.1x | 34.9x | 7.17x | 3.16x | 1.95x | 1.5x |
| EV / EBITDA | -14.6x | -17.9x | -17.7x | -25.4x | -39.7x | -18.3x | 18x | 7.34x |
| EV / EBIT | -14.1x | -17.3x | -17.2x | -24.1x | -32.9x | -17.7x | 30.3x | 7.23x |
| EV / FCF | -12x | -26.6x | -33.1x | -24.1x | -28.4x | -26.9x | 19.5x | 5.43x |
| FCF Yield | -8.31% | -3.76% | -3.02% | -4.15% | -3.52% | -3.72% | 5.14% | 18.4% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.56 | -2.74 | -2.8 | -2.94 | -0.96 | -1.62 | -0.12 | 1.471 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 75.68 | 89.79 | 117 | 285.1 | 627.2 | 1,029 | 1,454 | 1,810 |
| EBITDA 1 | -220.8 | -360.6 | -443.2 | -392.1 | -113.2 | -107.5 | 157.4 | 369.8 |
| EBIT 1 | -229.2 | -373 | -455.8 | -412.6 | -136.5 | -136.5 | 93.8 | 375.5 |
| Net income 1 | -303.5 | -386.2 | -446.3 | -518.3 | -177 | -296.8 | 47.08 | 297.4 |
| Net Debt 1 | -502.3 | -729.5 | -501.5 | -979.4 | -1,473 | -346.8 | -772.2 | -898.3 |
| Reference price 2 | 28.16 | 46.61 | 49.92 | 60.17 | 32.54 | 19.56 | 19.56 | 19.56 |
| Nbr of stocks (in thousands) | 132,638 | 153,946 | 167,403 | 181,789 | 183,451 | 184,690 | 184,690 | - |
| Announcement Date | 3/18/21 | 3/18/22 | 3/30/23 | 3/11/24 | 3/11/25 | 3/10/26 | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.27x | 3.16x | -18.27x | -.--% | 3.61B | |
| 43.19x | 10.11x | 36.48x | 0.03% | 45.56B | |
| 16.15x | 5.76x | 12.69x | 1.85% | 40.81B | |
| -53.49x | 18.02x | -59.54x | -.--% | 31.01B | |
| -16.58x | 2.76x | -13.85x | -.--% | 21.05B | |
| 28.08x | 5.79x | 16.09x | -.--% | 19.37B | |
| 22.45x | 4.26x | 13.93x | -.--% | 17.15B | |
| -329.86x | 27.4x | 1508.36x | -.--% | 13.54B | |
| -14.37x | 6424.77x | -18.36x | -.--% | 12.66B | |
| -172.74x | 42.14x | -167.37x | -.--% | 12.33B | |
| Average | -48.94x | 654.42x | 131.01x | 0.19% | 21.71B | |
| Weighted average by Cap. | -24.30x | 385.80x | 85.93x | 0.35% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- LEGN Stock
- Valuation Legend Biotech Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition